Inicio › Enfermedad de Crohn › Tennessee
Ensayos clínicos de Enfermedad de Crohn en Tennessee
11 estudios sobre Enfermedad de Crohn buscan participantes en Tennessee.
Ciudades en Tennessee
Texto oficial del estudio (inglés)
A Study of SL-325 in Crohn's Disease Patients
- Clinical Trial Site, Nashville
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07753850A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Vanderbilt Inflammatory Bowel Disease Clinic ( Site 5049), Nashville
- Quality Medical Research ( Site 5114), Nashville
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 10 nov 2026 · NCT06430801Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Center Of The Midsouth, Cordova
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937099A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Gastrointestinal Associates of Northeast Tennessee, Johnson City
ReclutandoFase 2
Edades de 18 a 85 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06226883A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Gastro One, Cordova
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07577843A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Tri-Cities Gastroenterology, Kingsport
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 28 oct 2026 · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastrointestinal Associates - Knoxville - Dowell Springs Boulevard /ID# 283861, Knoxville
- Gastro One - Memphis /ID# 283948, Memphis
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07697456An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Gastro One - Cordova-Site Number: 8400158, Cordova
- Tri-Cities Gastroenterology-Site Number: 8400076, Kingsport
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 21 oct 2026 · NCT07184931Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- GI associates of Northeast Tennessee /ID# 265567, Johnson City
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06548542Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Vanderbilt University Medical Center, Nashville
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 abr 2026 · NCT06456593A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Cordova
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 12 mar 2026 · NCT07113522De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.